SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-214907
Filing Date
2020-08-10
Accepted
2020-08-10 16:06:22
Documents
65
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d830818d10q.htm   iXBRL 10-Q 1160393
2 EX-31.1 d830818dex311.htm EX-31.1 10178
3 EX-31.2 d830818dex312.htm EX-31.2 10163
4 EX-32.1 d830818dex321.htm EX-32.1 4271
5 EX-32.2 d830818dex322.htm EX-32.2 4339
  Complete submission text file 0001193125-20-214907.txt   5031175

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cprx-20200630.xsd EX-101.SCH 39857
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20200630_cal.xml EX-101.CAL 38182
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20200630_def.xml EX-101.DEF 139578
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20200630_lab.xml EX-101.LAB 312952
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20200630_pre.xml EX-101.PRE 242353
11 EXTRACTED XBRL INSTANCE DOCUMENT d830818d10q_htm.xml XML 846026
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 201089372
SIC: 2834 Pharmaceutical Preparations